Using a protocol to manage antithrombotic medicines around surgery
Official title: Effect of Protocol-based Management on Perioperative Outcomes in Patients With Chronic Antithrombotic Therapy: a Pragmatic Interventional Study
Run by Peking University First Hospital · NCT04852406 · Data updated 2026-11-12
This study will test whether following a specific protocol for managing blood thinners before, during, and after surgery reduces bleeding and clotting complications in people on long-term antithrombotic therapy.
Quick facts
| Study type | Interventional |
|---|---|
| Sex | All |
| Enrollment | 526 (estimated) |
| Sponsor | Peking University First Hospital Academic / other |
| Locations | 1 site (Beijing, Beijing Municipality) |
| Status | Recruiting |
| Started | April 21, 2021 |
| Main results expected | December 2025 |
| Study ends | January 2026 |
| Registry record updated | July 31, 2025 |
| Trial ID | NCT04852406 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults on chronic antithrombotic therapy (antiplatelet and/or anticoagulant for >2 weeks) with high thrombotic risk (for example high CHA2DS2-VASc, recent valve replacement, recent VTE, recent stent/CABG, or recent stroke) who are planning elective surgery.
✕Probably not a fit
Patients not taking chronic antithrombotic medications, those with low thrombotic risk, or those needing urgent or emergency surgery are unlikely to benefit from this perioperative protocol.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This pragmatic interventional trial randomizes patients on chronic antithrombotic therapy to protocol-based perioperative management versus routine care to compare a composite of perioperative outcomes. Eligible patients are those taking antiplatelet and/or anticoagulant drugs for cardiovascular or cerebrovascular disease and meeting high-risk criteria who are scheduled for surgery. The protocol is based on multidisciplinary guideline and expert-consensus recommendations and standardizes timing of drug withholding, bridging, and resumption. Outcomes include perioperative bleeding, thrombotic events, and other perioperative complications collected at a single tertiary hospital site.
Why it matters
Potential benefit: If successful, the protocol could reduce bleeding and thrombotic complications and make perioperative anticoagulant care safer and more consistent for patients.
How similar studies have gone: Guidelines and expert consensus support protocolized antithrombotic management, but randomized and pragmatic data on clinical outcome benefits are limited and evidence is scarce.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * 1\. Patients with continuing antithrombotic therapy (including antiplatelet and/or anticoagulant therapies) for cardiovascular and cerebrovascular diseases for more than 2 weeks. * 2\. Patients who have one or more of the following situations: (1) non-valvular atrial fibrillation with a CHA2DS2-VASc score \>4; (2) post-artificial valve replacement (including mitral valve, ball-cage valve or tilting disc aortic valve); (3) venous thromboembolism occurred within 1 year, or venous thromboembolism with other high-risk factors which require long-term anticoagulation treatment; (4) coronary heart disease with coronary stent implantation, thrombolytic therapy or other coronary procedures within 2 years, or who had undergone coronary artery bypass grafting within 1 year, or who experienced myocardial infarction or acute coronary syndrome within 1 year; (5) a history of stroke/transient ischemic accident within 1 year, or a history of cervical or intracranial revascularization treatment within 1 year; (6) peripheral arterial disease. * 3\. Patients who are scheduled to undergo intra-abdominal surgery (including general and urologic surgery). * 4\. Patients who sign written informed consents. Exclusion Criteria: * 1\. Refuse to participate. * 2\. Emergency surgery. * 3\. Unable to complete the preoperative assessment and follow-up plan. * 4\. Other reasons that are considered unsuitable for study participation by the investigators or the attending doctors.
Where it's running
-
Peking University First Hospital
Beijing, Beijing Municipality, China Recruiting
Study contacts
- Principal investigator: Hong Zhang — Peking University First Hospital
- Study coordinator: Hong Zhang, MD
- Email: zhanghong40@hotmail.com
- Phone: 86 10 83572784
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Energy needs after head and neck cancer surgery with free flap reconstruction
This study tests how many calories people need before and after free flap surgery for head and neck cancer and whether nutrition relates to recovery and complications.
-
A new treatment model for elderly lung cancer patients
This trial tests a comprehensive, integrated care approach for older adults with lung cancer to improve perioperative management and outcomes.
-
Guiding anesthesia with CoreSys during open abdominal hysterectomy
This trial will test whether using CoreSys monitoring to guide anesthesia in women having elective open abdominal hysterectomy reduces inflammatory and hormonal stress responses after surgery.
-
Surgical techniques and outcomes across the lifespan in congenital heart disease in China
See which surgical factors and care patterns affect recovery after heart surgery for people with complex congenital heart disease in China.
-
Giving Children a Voice in Pediatric Anesthesia
This project tests whether asking children, parents, and clinicians about priorities can shape future pediatric anesthesia research in Switzerland.
-
Comparing CCI and POSSUM to predict complications after gynecologic cancer surgery
This project will test whether the Charlson Comorbidity Index (CCI) or the POSSUM score better predicts perioperative complications in adults having elective gynecologic cancer surgery.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.